EUVIMEDEUVIMED entdecken
Crossref

Functional Switching of BLT1 via Graded Phosphorylation: Transition From a High‐Affinity Form‐Mediated ERK Pathway to a Low‐Affinity State‐Mediated PI3K ‐ AKT Pathway

Nahoki Higuchi, Seiya Matsune, Junken Aoki, Asuka Inoue, Motonao Nakamura iD

Genes to Cells · 2026-11 · 31 (6)

DOI: 10.1111/gtc.70158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes to Cells, online erschienen am 03.11.2026. Verfasst von Nahoki Higuchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience, Graduate School of Life Science, Okayama University of Science, Okayama, Japan. Hauptthemen laut MEDLINE: Receptors, Leukotriene B4, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, MAP Kinase Signaling System. Die Arbeit nennt 52 Literaturangaben. Gefördert von: KAKENHI, Naito Foundation, Ryobi-teien Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BLT1, activated by leukotriene B 4 (LTB 4 ), triggers diverse neutrophil responses in a ligand concentration‐dependent manner: migration begins at low‐LTB 4 , whereas degranulation requires high concentrations. How BLT1 discriminates between these two regimes has remained unclear. Here, by analyzing BLT mutants lacking specific phosphorylation sites and examining chemotaxis and β‐hexosaminidase release, we reveal that this regulation is governed by a four‐stage phosphorylation process in the C‐terminus. Stage‐1‐phos (Ser 314 and Ser 320 ) involves a post‐translational modification essential for the recruitment of β‐arrestin1/2 to BLT1. Stage‐2‐phos (Ser 310 ) occurs immediately after stimulation with low‐LTB 4 . This modification triggers β‐arrestin1/2 recruitment (in coordination with Stage‐1‐phos), termination of ERK1/2 signaling, and the subsequent structural conversion of BLT1 to a low‐affinity state. Loss of Stage‐2‐phos left migration at low‐LTB 4 intact but caused sustained ERK1/2 activation and impaired chemotaxis at high‐LTB 4 . Stage‐3‐phos (Thr 308 ) occurs upon BLT1 reactivation by high‐LTB 4 and is essential for the subsequent Stage‐4‐phos. Stage‐4‐phos (Ser 313 , Thr 315 , and Thr 324 ) alters the association state of the BLT1‐β‐arrestin1/2 complex, activates PI3K/AKT pathway, and initiates degranulation. Deficiency in either Stage‐3‐phos or Stage‐4‐phos abolished AKT activation and β‐hexosaminidase release while leaving ERK1/2 activation intact. Thus, stepwise phosphorylation enables BLT1 to sense the ambient LTB 4 concentration and switch its output from ERK1/2 to PI3K‐AKT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Leukotriene B4Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesMAP Kinase Signaling SystemPhosphorylationHumansLeukotriene B4AnimalsSignal TransductionChemotaxisNeutrophilsbeta-Arrestins

Stichwörter der Autor:innen

BLT1GPCRchemotaxisdegranulationleukotriene B4phosphorylation

Substanzen

Receptors, Leukotriene B4Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesLeukotriene B4LTB4R protein, humanbeta-Arrestins

Autor:innen und Institutionen

  • Department of Bioscience, Graduate School of Life Science, Okayama University of Science, Okayama, Japan.
  • Department of Health Chemistry, Graduate School of Pharmaceutical Science, The University of Tokyo, Tokyo, Japan.
  • Japan Agency for Medical Research and Development (AMED), Core Research for Evolutional Science and Technology (AMED-CREST), Tokyo, Japan.
  • Department of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.
  • Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.

ORCID-Profile: Motonao Nakamura

Förderung

  • KAKENHI
  • Naito Foundation
  • Ryobi-teien Foundation
  • Mitsubishi Foundation
  • Takeda Science Foundation
  • ONO Pharmaceutical Foundation
  • Science Research Promotion Fund, the Promotion and Mutual Aid Corporation for Private Schools of Japan
  • JST

Zitieren

APA

Higuchi, N., Matsune, S., Aoki, J., Inoue, A., & Nakamura, M. (2026). Functional Switching of BLT1 via Graded Phosphorylation: Transition From a High‐Affinity Form‐Mediated ERK Pathway to a Low‐Affinity State‐Mediated PI3K ‐ AKT Pathway. Genes to Cells, 31(6). https://doi.org/10.1111/gtc.70158

Vancouver

Higuchi N, Matsune S, Aoki J, Inoue A, Nakamura M. Functional Switching of BLT1 via Graded Phosphorylation: Transition From a High‐Affinity Form‐Mediated ERK Pathway to a Low‐Affinity State‐Mediated PI3K ‐ AKT Pathway. Genes to Cells. 2026;31(6). doi:10.1111/gtc.70158

BibTeX
@article{Higuchi2026,
  author = {Higuchi, Nahoki and Matsune, Seiya and Aoki, Junken and Inoue, Asuka and Nakamura, Motonao},
  title = {Functional Switching of BLT1 via Graded Phosphorylation: Transition From a High‐Affinity Form‐Mediated ERK Pathway to a Low‐Affinity State‐Mediated PI3K ‐ AKT Pathway},
  journal = {Genes to Cells},
  year = {2026},
  volume = {31},
  number = {6},
  doi = {10.1111/gtc.70158}
}
Kostenlos starten →